"Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation"
Hawon Woo#, Yeonseo Jang#, Soyeon Kim, Wonyoung Kim, Fenfen Zhang, Raghvendra Mall, Chirag N Patel, Melan Kurera, Chinh Ngo, Simon H Jiang, Asia Nicotra, Bénédicte F Py, Min Zheng*, Si Ming Man*, Rajendra Karki*, EMBO Molecular Medicine, 2026, 18, 2124-2151